glp 1 sanofi agonist GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know GLP-1 Agonists: A Comprehensive Overview

Description

Lozenges: Like oral drops, they contain the same active ingredients as the brand name GLP-1s but are produced by compounding pharmacies and are not approved by the FDA

In 2023, Juan P Frias and colleagues, in The Lancet, published the first phase two clinical trial of orforglipron, which investigated the use of a small-molecule oral GLP-1R agonist called orforglipron in type 2 diabetes, which can be taken at any time of the day without restrictions on food and water intake (Frias et al., 2023)

Understanding how these medications work and what to realistically expect can help you make informed decisions about your treatment

Some people tolerate tirzepatide with no sulfur burps but cannot handle semaglutide, and vice versa

GLP-1s can suppress appetite so much that patients under-eat, leading to micronutrient depletionparticularly of zinc, magnesium, and B vitamins, all essential for hormone production